Literature DB >> 16937502

Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer.

George Theodoropoulos1, Ioannis Papaconstantinou, Evangelos Felekouras, Nikolaos Nikiteas, Petros Karakitsos, Dimitris Panoussopoulos, Andreas Ch Lazaris, Efstratios Patsouris, John Bramis, Maria Gazouli.   

Abstract

AIM: To investigate the association between common single nucleotide polymorphisms (SNPs) in inflammatory response-related genes such as interleukin (IL)-6, IL-8, tumor necrosis factor alpha (TNFalpha), peroxisome proliferators-activated receptor gamma (PPARgamma), intercellular adhesion molecule-1 (ICAM-1) and the risk of colorectal cancer (CRC) in a group of Greek patients.
METHODS: The study group consisted of 222 CRC patients and 200 healthy controls. Genotyping was performed using allele-specific PCR of PRC-RFLP and the results were confirmed by sequencing. We studied the association of SNPs in the IL-6 (-174G>C), IL-8 (-251T>A), TNFalpha (-308G>A), ICAM-1 (R241G and K469E), and PPARgamma (Pro12Ala) genes and the risk of CRC.
RESULTS: The IL-6 -174G, R241 and K469 alleles of ICAM-1 were associated with increased risk of CRC (OR = 1.77, 95% CI: 1.34-2.34; OR = 1.83, 95% CI: 1.23-2.72; and OR = 1.35, 95% CI: 1.03-1.77 respectively). The IL-8 and TNFalpha polymorphisms had no effect. Whereas the PPARgamma Pro12 genotype was associated with increased risk of disease (OR = 1.78, 95% CI: 1.25-2.49).
CONCLUSION: The association between common SNPs in immunologic response-related genes and CRC is reported in the present study. Apart from shedding light on the mechanisms of malignancy initiation and progression, SNPs may improve appropriate screening for sub-populations at risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937502      PMCID: PMC4087409          DOI: 10.3748/wjg.v12.i31.5037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  The -174 C/G locus affects in vitro/in vivo IL-6 production during aging.

Authors:  Fabiola Olivieri; Massimiliano Bonafè; Luca Cavallone; Simona Giovagnetti; Francesca Marchegiani; Maurizio Cardelli; Elena Mugianesi; Claudia Giampieri; Raffaella Moresi; Rosalia Stecconi; Rosamaria Lisa; Claudio Franceschi
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

2.  Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.

Authors:  K Warzocha; G Salles; J Bienvenu; Y Bastion; C Dumontet; N Renard; E M Neidhardt-Berard; B Coiffier
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

3.  Polymorphisms of tumour necrosis factors A and B in breast cancer.

Authors:  K S Park; J W Mok; H E Ko; K Tokunaga; M H Lee
Journal:  Eur J Immunogenet       Date:  2002-02

Review 4.  Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.

Authors:  Nicola S Fearnhead; Jennifer L Wilding; Walter F Bodmer
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

5.  Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.

Authors:  Mark A Vickers; Fiona R Green; Catherine Terry; Bongani M Mayosi; Cecile Julier; Mark Lathrop; Peter J Ratcliffe; Hugh C Watkins; Bernard Keavney
Journal:  Cardiovasc Res       Date:  2002-03       Impact factor: 10.787

Review 6.  Molecular and genetic defects in colorectal tumorigenesis.

Authors:  Sabine Tejpar; Eric Van Cutsem
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-04       Impact factor: 3.043

7.  Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.

Authors:  Miyuki Toyota; Yoshiji Miyazaki; Shinji Kitamura; Yutaka Nagasawa; Tatsuya Kiyohara; Yasuhisa Shinomura; Yuji Matsuzawa
Journal:  Life Sci       Date:  2002-02-15       Impact factor: 5.037

8.  Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene.

Authors:  Manami Hara; Sergio Y Alcoser; Arshia Qaadir; Kristina K Beiswenger; Nancy J Cox; David A Ehrmann
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

9.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.

Authors:  Céu Figueiredo; José Carlos Machado; Paul Pharoah; Raquel Seruca; Sónia Sousa; Ralph Carvalho; Ana Filipa Capelinha; Wim Quint; Carlos Caldas; Leen-Jan van Doorn; Fátima Carneiro; Manuel Sobrinho-Simões
Journal:  J Natl Cancer Inst       Date:  2002-11-20       Impact factor: 13.506

10.  Influence of cytokine gene polymorphisms on the development of prostate cancer.

Authors:  Sarah L McCarron; Stephen Edwards; Philip R Evans; Roz Gibbs; David P Dearnaley; Anna Dowe; Christine Southgate; Douglas F Easton; Rosalind A Eeles; W Martin Howell
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  65 in total

Review 1.  IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.

Authors:  Yong Yu; Wenjun Wang; Song Zhai; Shuangsuo Dang; Mingzhu Sun
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

2.  Association of PTEN gene polymorphisms with liver cancer risk.

Authors:  Hong-Guang Li; Fang-Feng Liu; Hua-Qiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jin-Hua Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Ziliang Wang; Yang Liu; Lina Yang; Sheng Yin; Rongyu Zang; Gong Yang
Journal:  Tumour Biol       Date:  2014-04-24

Review 4.  TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis.

Authors:  Xu-Feng Guo; Jun Wang; Shi-Jie Yu; Jia Song; Meng-Yao Ji; Zhuo Cao; Ji-Xiang Zhang; Jing Wang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

5.  Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk.

Authors:  Wei Wang; Yan Shao; Shenhua Tang; Xianyong Cheng; Haifeng Lian; Chengyong Qin
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  The genetic polymorphisms of intercellular cell adhesion molecules and breast cancer susceptibility: a meta-analysis.

Authors:  Lin Liu; Meili Sun; Degang Song; Zhehai Wang
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

7.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

8.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Authors:  Hansong Wang; Darin Taverna; Daniel O Stram; Barbara K Fortini; Iona Cheng; Lynne R Wilkens; Terrilea Burnett; Karen W Makar; Noralane M Lindor; John L Hopper; Steve Gallinger; John A Baron; Robert Haile; Laurence N Kolonel; Brian E Henderson; Polly A Newcomb; Graham Casey; David Duggan; Cornelia M Ulrich; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

9.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

10.  Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.

Authors:  Konstantina Vogiatzi; Stavros Apostolakis; Vassilios Voudris; Sophia Thomopoulou; Georgios E Kochiadakis; Demetrios A Spandidos
Journal:  J Clin Immunol       Date:  2008-04-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.